HF
UTMD icon

HRT Financial’s Utah Medical Products UTMD Stock Holding History

HRT Financial’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,157
Closed -$373K – 3775
2022
Q1 		$373K Buy
+4,157
New +$382K ﹤0.01% 2083
2020
Q3 		– Sell
-7,610
Closed -$674K – 2392
2020
Q2 		$674K Buy
+7,610
New +$683K 0.02% 667
2019
Q4 		– Sell
-2,128
Closed -$203K – 1671
2019
Q3 		$203K Buy
+2,128
New +$198K 0.01% 1146

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

HRT Financial's UTMD Position: Q2 2022 in Review

HRT Financial sold out of Utah Medical Products (UTMD) in Q2 2022, closing a stake of 4,157 shares — an estimated $373K sold.

HRT Financial first reported a position in UTMD in Q3 2019 and held it in 3 quarters. The position peaked at $674K in Q2 2020. 75 funds tracked by Wall St. Rank hold UTMD as of Q2 2022.

  • HRT Financial reported no remaining Utah Medical Products position as of Q2 2022 after selling out during the quarter.
  • HRT Financial sold 4,157 Utah Medical Products shares in Q2 2022, an estimated $373K.
  • HRT Financial first reported a position in Utah Medical Products in Q3 2019 and held it in 3 quarters.
  • HRT Financial's Utah Medical Products position peaked at $674K in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2022.

Based on HRT Financial's 13F filing for Q2 2022, filed 12 Aug 2022.